Ubiquitin Variant With High Affinity for Binding 53BP1 Reduces the Amount of AAV Needed to Achieve High Rates of HDR
Copyright © Targeted News Service 2026
2026-09-22
ALEXANDRIA, Virginia, Sept. 22 -- INTEGRATED DNA TECHNOLOGIES, INC., Coralville, Iowa has been assigned a patent (No. US 12741995 B2, initially filed Aug. 15, 2023) developed by three inventors Steve Ehren Glenn, North Liberty, Iowa; Michael Allen Collingwood, Solon, Iowa; and Christopher Anthony Vakulskas, North Liberty, Iowa, for "Ubiquitin variant with high affinity for binding 53BP1 reduces the amount of AAV needed to achieve high rates of HDR." . . .
